| 1 |
Drug Repurposing: An Effective Tool in Modern Drug Discovery |
|
|
| V. S. Kulkarni, V. Alagarsamy, V. R. Solomon, P. A. Jose, S. Murugesan |
|
| Russian Journal of Bioorganic Chemistry. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Access to medicines for rare diseases: A European regulatory roadmap for academia |
|
|
| Noa Rosenberg, Sibren van den Berg, Nina N. Stolwijk, Bart A. W. Jacobs, Hendrika C. Post, Anna M. G. Pasmooij, Saco J. de Visser, Carla E. M. Hollak |
|
| Frontiers in Pharmacology. 2023; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Prediction of Drug-Related Diseases Through Integrating Pairwise Attributes and Neighbor Topological Structures |
|
|
| Yingying Song, Hui Cui, Tiangang Zhang, Tingxiao Yang, Xiaokun Li, Ping Xuan |
|
| IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2022; 19(5): 2963 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The Neural Metric Factorization for Computational Drug Repositioning |
|
|
| Xinxing Yang, Genke Yang, Jian Chu |
|
| IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2022; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing |
|
|
| Fan Zhang, Wei Hu, Yirong Liu |
|
| BMC Bioinformatics. 2022; 23(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Learning multi-scale heterogenous network topologies and various pairwise attributes for drug–disease association prediction |
|
|
| Hongda Zhang, Hui Cui, Tiangang Zhang, Yangkun Cao, Ping Xuan |
|
| Briefings in Bioinformatics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Heterogeneous multi-scale neighbor topologies enhanced drug–disease association prediction |
|
|
| Ping Xuan, Xiangfeng Meng, Ling Gao, Tiangang Zhang, Toshiya Nakaguchi |
|
| Briefings in Bioinformatics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Drug repositioning based on heterogeneous networks and variational graph autoencoders |
|
|
| Song Lei, Xiujuan Lei, Lian Liu |
|
| Frontiers in Pharmacology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Integration of Neighbor Topologies Based on Meta-Paths and Node Attributes for Predicting Drug-Related Diseases |
|
|
| Ping Xuan, Zixuan Lu, Tiangang Zhang, Yong Liu, Toshiya Nakaguchi |
|
| International Journal of Molecular Sciences. 2022; 23(7): 3870 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron–Schwann Cell Co-Cultures |
|
|
| Shizuka Takaku, Kazunori Sango |
|
| International Journal of Molecular Sciences. 2022; 23(17): 9983 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Locally Applied Repositioned Hormones for Oral Bone and Periodontal Tissue Engineering: A Narrative Review |
|
|
| Gamal Abdel Nasser Atia, Hany K. Shalaby, Mehrukh Zehravi, Mohamed Mohamady Ghobashy, Zubair Ahmad, Farhat S. Khan, Abhijit Dey, Md. Habibur Rahman, Sang Woo Joo, Hasi Rani Barai, Simona Cavalu |
|
| Polymers. 2022; 14(14): 2964 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Review of bioinformatics in Azheimer's Disease Research |
|
|
| Shida He, Lijun Dou, Xuehong Li, Ying Zhang |
|
| Computers in Biology and Medicine. 2022; : 105269 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
RP-HPLC method development, validation, and drug repurposing of sofosbuvir pharmaceutical dosage form: A multidimensional study |
|
|
| Ghulam Rasool Mangrio, Apichit Maneengam, Zunera Khalid, Tassadaq Hussain Jafar, Ghulam Qadir Chanihoon, Rayan Nassani, Ahsanullah Unar |
|
| Environmental Research. 2022; : 113282 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Probenecid induces the recovery of renal ischemia/reperfusion injury via the blockade of Pannexin 1/P2X7 receptor axis |
|
|
| Walaa H. El-Maadawy, Marwa Hassan, Mohamed H. Badawy, AbdulRahman AbuSeada, Ehab Hafiz |
|
| Life Sciences. 2022; 308: 120933 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
A systematic review on data mining application in Parkinson's disease |
|
|
| Adesh Kumar Srivastava, Klinsega Jeberson, Wilson Jeberson |
|
| Neuroscience Informatics. 2022; : 100064 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P-gp- and STAT3-Mediated Chemoresistance |
|
|
| Libor Kostka, Ladislav Sivák, Vladimír Šubr, Jirina Kovárová, Milada Šírová, Blanka Ríhová, Radislav Sedlacek, Tomáš Etrych, Marek Kovár |
|
| Biomacromolecules. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Daptomycin suppresses tumor migration and angiogenesis via binding to ribosomal protein S19 in humans |
|
|
| Sung Min Cho, Hwa Jung Lee, Peter Karuso, Ho Jeong Kwon |
|
| The Journal of Antibiotics. 2021; 74(10): 726 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs |
|
|
| Farzin Sohraby, Hassan Aryapour |
|
| Seminars in Cancer Biology. 2021; 68: 249 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Repurposing old molecules for new indications: Defining pillars of success from lessons in the past |
|
|
| Niti Mittal, Rakesh Mittal |
|
| European Journal of Pharmacology. 2021; 912: 174569 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care Improvement |
|
|
| Davide Grisafi, Alessandro Ceschi, Veronica Avalos Clerici, Francesco Scaglione |
|
| Current Therapeutic Research. 2021; 94: 100628 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Drug repurposing of dextromethorphan as a cellular target for the management of influenza |
|
|
| Tammy H. Cummings, Joseph Magagnoli, James W. Hardin, S. Scott Sutton |
|
| Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2021; 41(10): 796 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Repurposing Small Molecules to Target PPAR-? as New Therapies for Peripheral Nerve Injuries |
|
|
| Melissa L. D. Rayner, Jess Healy, James B. Phillips |
|
| Biomolecules. 2021; 11(9): 1301 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Natural Products Are a Promising Source for Anthelmintic Drug Discovery |
|
|
| K. L. T. Dilrukshi Jayawardene, Enzo A. Palombo, Peter R. Boag |
|
| Biomolecules. 2021; 11(10): 1457 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Graph Convolutional Autoencoder and Fully-Connected Autoencoder with Attention Mechanism Based Method for Predicting Drug-Disease Associations |
|
|
| Ping Xuan, Ling Gao, Nan Sheng, Tiangang Zhang, Toshiya Nakaguchi |
|
| IEEE Journal of Biomedical and Health Informatics. 2021; 25(5): 1793 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing |
|
|
| Natalie K. Boyd, Chengwen Teng, Christopher R. Frei |
|
| Frontiers in Cellular and Infection Microbiology. 2021; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates |
|
|
| Michal Antoszczak, Anna Markowska, Janina Markowska, Adam Huczynski |
|
| Current Medicinal Chemistry. 2021; 28(11): 2137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Developing Novel Anticancer Drugs for Targeted Populations: An Update |
|
|
| Tadesse B. Tafesse, Mohammed H. Bule, Fazlullah Khan, Mohammad Abdollahi, Mohsen Amini |
|
| Current Pharmaceutical Design. 2021; 27(2): 250 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Prediction of drug–disease associations by integrating common topologies of heterogeneous networks and specific topologies of subnets |
|
|
| Ling Gao, Hui Cui, Tiangang Zhang, Nan Sheng, Ping Xuan |
|
| Briefings in Bioinformatics. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Will the COVID-19 Pandemic Finally Fuel Drug Repurposing Efforts? |
|
|
| Anna Chen, Shivangi Patel, Matthew Alcusky, Vittorio Maio |
|
| American Journal of Medical Quality. 2021; 36(2): 122 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
The Current Challenges for Drug Discovery in CNS Remyelination |
|
|
| Sonia Balestri, Alice Del Giovane, Carola Sposato, Marta Ferrarelli, Antonella Ragnini-Wilson |
|
| International Journal of Molecular Sciences. 2021; 22(6): 2891 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs |
|
|
| Nuno Vale, Maria João Gouveia, Fátima Gärtner |
|
| Biomolecules. 2020; 10(3): 350 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Drug repurposing against Parkinson's disease by text mining the scientific literature |
|
|
| Yongjun Zhu, Woojin Jung, Fei Wang, Chao Che |
|
| Library Hi Tech. 2020; 38(4): 741 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
NF-?B Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress—A Reprofiling Approach |
|
|
| Awais Ali, Fawad Ali Shah, Alam Zeb, Imran Malik, Arooj Mohsin Alvi, Lina Tariq Alkury, Sajid Rashid, Ishtiaq Hussain, Najeeb Ullah, Arif Ullah Khan, Phil Ok Koh, Shupeng Li |
|
| Frontiers in Molecular Neuroscience. 2020; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Biapenem as a Novel Insight into Drug Repositioning against Particulate Matter-Induced Lung Injury |
|
|
| Wonhwa Lee, Moon-Chang Baek, Kyung-Min Kim, Jong-Sup Bae |
|
| International Journal of Molecular Sciences. 2020; 21(4): 1462 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Recycling the Purpose of Old Drugs to Treat Ovarian Cancer |
|
|
| Mariana Nunes, Miguel Henriques Abreu, Carla Bartosch, Sara Ricardo |
|
| International Journal of Molecular Sciences. 2020; 21(20): 7768 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review |
|
|
| William Gustavo Lima, Júlio César Moreira Brito, Joerg Overhage, Waleska Stephanie da Cruz Nizer |
|
| Archives of Virology. 2020; 165(8): 1729 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents |
|
|
| Suzana Gonçalves Carvalho, Daniel Fernandes Cipriano, Jair Carlos Checon de Freitas, Miguel Ângelo Schettino Junior, Enrique Ronald Yapuchura Ocaris, Carolina Bioni Garcia Teles, Aurileya de Jesus Gouveia, Ricardo Pereira Rodrigues, Marcos Santos Zanini, Janaína Cecília Oliveira Villanova |
|
| Drug Delivery and Translational Research. 2020; 10(6): 1788 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Identification of novel analgesics through a drug repurposing strategy |
|
|
| Parisa Gazerani |
|
| Pain Management. 2019; 9(4): 399 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Drug repositioning through integration of prior knowledge and projections of drugs and diseases |
|
|
| Ping Xuan, Yangkun Cao, Tiangang Zhang, Xiao Wang, Shuxiang Pan, Tonghui Shen, Jonathan Wren |
|
| Bioinformatics. 2019; 35(20): 4108 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach |
|
|
| An Ning Cheng, Yu-Kang Lo, Yi-Sheng Lin, Tswen-Kei Tang, Chun-Hua Hsu, John T.-A. Hsu, Alan Yueh-Luen Lee |
|
| EBioMedicine. 2018; 36: 241 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Clotrimazole inhibits the Wnt/ß-catenin pathway by activating two eIF2a kinases: The heme-regulated translational inhibitor and the double-stranded RNA-induced protein kinase |
|
|
| Honami Yonezawa, Mami Ogawa, Sota Katayama, Yui Shimizu, Norikazu Omori, Yusuke Oku, Tomoko Sakyo, Yoshimasa Uehara, Naoyuki Nishiya |
|
| Biochemical and Biophysical Research Communications. 2018; 506(1): 183 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent |
|
|
| Bassam M. Ayoub, Shereen Mowaka, Marwa M. Safar, Nermeen Ashoush, Mona G. Arafa, Haidy E. Michel, Mariam M. Tadros, Mohamed M. Elmazar, Shaker A. Mousa |
|
| Scientific Reports. 2018; 8(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Common Dysregulation of Ribosomal Genes Present in Infants with Acute Respiratory Infection of Respiratory Syncytial Virus, Rhinovirus, and Influenza A |
|
|
| Huilan Zhu,Xinxin Xin |
|
| Pediatric Allergy, Immunology, and Pulmonology. 2015; 28(1): 32 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Anti-inflammatory effects of methylthiouracil in vitro and in vivo |
|
|
| Sae-Kwang Ku,Moon-Chang Baek,Jong-Sup Bae |
|
| Toxicology and Applied Pharmacology. 2015; 288(3): 374 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Novel insight into drug repositioning: Methylthiouracil as a case in point |
|
|
| Moon-Chang Baek,Byeongjin Jung,Hyejin Kang,Hyun-Shik Lee,Jong-Sup Bae |
|
| Pharmacological Research. 2015; 99: 185 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
In vitro anti-osteoclastogenic activity of p38 inhibitor doramapimod via inhibiting migration of pre-osteoclasts and NFATc1 activity |
|
|
| Seong-Hee Moon,Sik-Won Choi,Seong Hwan Kim |
|
| Journal of Pharmacological Sciences. 2015; 129(3): 135 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption |
|
|
| D. Yugandhar,V. Lakshma Nayak,Sivakumar Archana,Kunta Chandra Shekar,Ajay Kumar Srivastava |
|
| European Journal of Medicinal Chemistry. 2015; 101: 348 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
Ameliorative effect of methylthiouracil on TGFBIp-induced septic responses |
|
|
| Byeongjin Jung,Sae-Kwang Ku,Jong-Sup Bae |
|
| Biochemical and Biophysical Research Communications. 2015; 463(4): 661 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands |
|
|
| Germán M. Pérez,Luis A. Salomón,Luis A. Montero-Cabrera,José M. García de la Vega,Marcello Mascini |
|
| Molecular Diversity. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Auranofin efficacy against MDRStreptococcus pneumoniaeandStaphylococcus aureusinfections |
|
|
| Leire Aguinagalde,Roberto Díez-Martínez,Jose Yuste,Inmaculada Royo,Carmen Gil,Íñigo Lasa,Mar Martín-Fontecha,Nagore Isabel Marín-Ramos,Carmen Ardanuy,Josefina Liñares,Pedro García,Ernesto García,José M. Sánchez-Puelles |
|
| Journal of Antimicrobial Chemotherapy. 2015; 70(9): 2608 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Methylthiouracil, a new treatment option for sepsis |
|
|
| Soyoung Kwak,Sae-Kwang Ku,Hyejin Kang,Moon-Chang Baek,Jong-Sup Bae |
|
| Vascular Pharmacology. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Prediction of Drug Indications Based on Chemical Interactions and Chemical Similarities |
|
|
| Guohua Huang,Yin Lu,Changhong Lu,Mingyue Zheng,Yu-Dong Cai |
|
| BioMed Research International. 2015; 2015: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Discontinued anxiolytic drugs (2009 – 2014) |
|
|
| Roberto Mandrioli,Laura Mercolini |
|
| Expert Opinion on Investigational Drugs. 2015; 24(4): 557 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
Engaging patients for drug repurposing: mapping the patient engagement continuum |
|
|
| Minna Allarakhia |
|
| Clinical Investigation. 2015; 5(9): 733 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
Identifying Gastric Cancer Related Genes Using the Shortest Path Algorithm and Protein-Protein Interaction Network |
|
|
| Yang Jiang,Yang Shu,Ying Shi,Li-Peng Li,Fei Yuan,Hui Ren |
|
| BioMed Research International. 2014; 2014: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 56 |
A Graphic Method for Identification of Novel Glioma Related Genes |
|
|
| Yu-Fei Gao,Yang Shu,Lei Yang,Yi-Chun He,Li-Peng Li,GuaHua Huang,Hai-Peng Li,Yang Jiang |
|
| BioMed Research International. 2014; 2014: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
Repositioning of 2,4-Dichlorophenoxy acetic acid as a potential anti-inflammatory agent: In Silico and Pharmaceutical Formulation study |
|
|
| Mohammed A. Khedr,Tamer M. Shehata,Maged E. Mohamed |
|
| European Journal of Pharmaceutical Sciences. 2014; 65: 130 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
Repurposing drugs for the treatment and control of helminth infections |
|
|
| Gordana Panic,Urs Duthaler,Benjamin Speich,Jennifer Keiser |
|
| International Journal for Parasitology: Drugs and Drug Resistance. 2014; 4(3): 185 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Challenges and opportunities of drug repositioning |
|
|
| Natalia Novac |
|
| Trends in Pharmacological Sciences. 2013; 34(5): 267 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 60 |
Open-source approaches for the repurposing of existing or failed candidate drugs: Learning from and applying the lessons across diseases |
|
|
| Allarakhia, M. |
|
| Drug Design, Development and Therapy. 2013; 7: 753-766 |
|
| [Pubmed] [Google Scholar] |
|
| 61 |
Challenges and opportunities of drug repositioning |
|
|
| Novac, N. |
|
| Trends in Pharmacological Sciences. 2013; 34(5): 267-272 |
|
| [Pubmed] [Google Scholar] |
|
| 62 |
Are GPCRs Still a Source of New Targets? |
|
|
| Stephen L. Garland |
|
| SLAS Discovery. 2013; 18(9): 947 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 63 |
Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs) |
|
|
| Ivan Molineris,Ugo Ala,Paolo Provero,Ferdinando Di Cunto |
|
| BMC Bioinformatics. 2013; 14(1): 288 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 64 |
Discontinued drugs in 2012: cardiovascular drugs |
|
|
| Hong-Ping Zhao,Hong-Min Jiang,Bing-Ren Xiang |
|
| Expert Opinion on Investigational Drugs. 2013; 22(11): 1437 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 65 |
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature |
|
|
| Murteira Susana,Ghezaiel Zied,Karray Slim,Lamure Michel |
|
| Journal of Market Access & Health Policy. 2013; 1(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 66 |
Systematic identification of small molecule adjuvants |
|
|
| Darren R Flower |
|
| Expert Opinion on Drug Discovery. 2012; 7(9): 807 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 67 |
Orphan/rare drug discovery through drug repositioning |
|
|
| Muthyala, R. |
|
| Drug Discovery Today: Therapeutic Strategies. 2012; 8(3-4): 71-76 |
|
| [Pubmed] [Google Scholar] |
|
| 68 |
Systematic identification of small molecule adjuvants |
|
|
| Flower, D.R. |
|
| Expert Opinion on Drug Discovery. 2012; 7(9): 807-817 |
|
| [Pubmed] [Google Scholar] |
|
| 69 |
The role of academic institutions in the development of drugs for rare and neglected diseases |
|
|
| Coles, L.D. and Cloyd, J.C. |
|
| Clinical Pharmacology and Therapeutics. 2012; 92(2): 193-202 |
|
| [Pubmed] [Google Scholar] |
|
| 70 |
Nonprofit drugs as the salvation of the worldæs healthcare systems: The case of Antabuse (disulfiram) |
|
|
| Cvek, B. |
|
| Drug Discovery Today. 2012; 17(9-10): 409-412 |
|
| [Pubmed] [Google Scholar] |
|
| 71 |
Cancer cell senescence: A new frontier in drug development |
|
|
| Cairney, C.J., Bilsland, A.E., Evans, T.R.J., Roffey, J., Bennett, D.C., Narita, M., Torrance, C.J., Keith, W.N. |
|
| Drug Discovery Today. 2012; 17(5-6): 269-276 |
|
| [Pubmed] [Google Scholar] |
|
| 72 |
Drug repositioning for personalized medicine |
|
|
| Li, Y.Y., Jones, S.J.M. |
|
| Genome Medicine. 2012; 4(3): art -27 |
|
| [Pubmed] [Google Scholar] |
|
| 73 |
Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis |
|
|
| Smith, S.B., Dampier, W., Tozeren, A., Brown, J.R., Magid-Slav, M. |
|
| PLoS ONE. 2012; 7(3): art -33174 |
|
| [Pubmed] [Google Scholar] |
|
| 74 |
Nonprofit drugs as the salvation of the worldæs healthcare systems: the case of Antabuse (disulfiram) |
|
|
| Boris Cvek |
|
| Drug Discovery Today. 2012; 17(9-10): 409 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 75 |
Cancer cell senescence: a new frontier in drug development |
|
|
| Claire J. Cairney,Alan E. Bilsland,T.R. Jeffry Evans,Jon Roffey,Dorothy C. Bennett,Masashi Narita,Christopher J. Torrance,W. Nicol Keith |
|
| Drug Discovery Today. 2012; 17(5-6): 269 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 76 |
The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases |
|
|
| L D Coles,J C Cloyd |
|
| Clinical Pharmacology & Therapeutics. 2012; 92(2): 193 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 77 |
Orphan/rare drug discovery through drug repositioning |
|
|
| Ramaiah Muthyala |
|
| Drug Discovery Today: Therapeutic Strategies. 2011; 8(3-4): 71 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
